Landscapes / Targets
CD40
16 drugs act on CD40, in 31 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs16
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Sanofi · Public SNY |
Phase 3 | 23 Dec 2026Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 23 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Multiple Sclerosis, Systemic Lupus Erythematosus and 4 more | ||||
| Open drug page | |||||
CD40 ligand (CD40L) antibody |
Eledon Pharmaceuticals · Public ELDN |
Phase 3 | Jan 2027Phase 1/2 trial completes | ||
| Next date | Jan 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Kidney Transplant Rejection, Prevention of Rejection in Kidney Transplant | ||||
| Open drug page | |||||
— |
Amgen · Public AMGN |
Phase 3 | 11 Dec 2029Phase 3 trial completes | ||
| Next date | 11 Dec 2029 · Phase 3 trial completes | ||||
| Also tested for | Sjögren's Syndrome (SS), Sjögren's Syndrome | ||||
| Open drug page | |||||
Monoclonal antibody |
AbbVie · Public ABBV |
Phase 2 | Feb 2027Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Rheumatoid Arthritis | ||||
| Open drug page | |||||
— |
Phase 2 | 31 May 2027Phase 2 trial completes | |||
| Next date | 31 May 2027 · Phase 2 trial completes | ||||
| Also tested for | Sepsis, Community Acquired Pneumonia (CAP) and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2027Phase 1 trial completes | |||
| Next date | Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC) and 4 more | ||||
| Open drug page | |||||
— |
Phase 2 | Aug 2027Phase 2 trial completes | |||
| Next date | Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Soft Tissue Sarcoma, Melanoma and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | |||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor, Claudin 18.2 and 1 more | ||||
| Open drug page | |||||
— |
Hengrui · Public 600276.SS |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | ||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
Monoclonal antibody |
Roche · Public ROG.SW |
Phase 1/2 | 30 Sep 2030Phase 1/2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 30 Sep 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Metastatic Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Metastatic Pancreatic Ductal Adenocarcinoma | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Nov 2026soonPhase 1 trial completes | |||
| Next date | 30 Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Jan 2027Phase 1 trial completes | |||
| Next date | 30 Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | Locally Advanced Rectal Cancer (LARC) | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Oct 2027Phase 1 trial completes | |||
| Next date | 1 Oct 2027 · Phase 1 trial completes | ||||
| Also tested for | Metastatic Melanoma | ||||
| Open drug page | |||||
— |
Phase 1 | Mar 2029Phase 1 trial completes | |||
| Next date | Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor and 4 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Malignant Tumors | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 16 of 16 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026